KLWA
Kelly Lawrence W & Associates Portfolio holdings
AUM
$382M
This Quarter Return
+2.63%
1 Year Return
+13.86%
3 Year Return
+61.56%
5 Year Return
+124.1%
10 Year Return
+368.26%
AUM
$473M
AUM Growth
+$473M
(+1.8%)
Cap. Flow
-$4.91M
Cap. Flow
% of AUM
-1.04%
Top 10 Holdings %
Top 10 Hldgs %
45.52%
Holding
158
New
1
Increased
16
Reduced
20
Closed
1
Top Buys
Top Sells
| 1 |
GE Aerospace
GE
|
$3.52M |
| 2 |
RC.PRD
Ready Capital Corporation 7.625% Series D Cumulative Redeemable Preferred Stock
RC.PRD
|
$326K |
| 3 |
Danaher
DHR
|
$215K |
| 4 |
Alphabet (Google) Class A
GOOGL
|
$209K |
| 5 |
Apple
AAPL
|
$146K |
Sector Composition
| 1 | Technology | 26.92% |
| 2 | Financials | 18.84% |
| 3 | Healthcare | 15.96% |
| 4 | Communication Services | 10.1% |
| 5 | Consumer Staples | 7.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Cisco
CSCO
$274B
| $6.02M | 1.27% |
110,585
| – | – |
|
27
Applied Materials
AMAT
$128B
| $5.97M | 1.26% |
46,395
| – | – |
|
28
Hexcel
HXL
$5.02B
| $5.45M | 1.15% |
91,820
-1,325
| -1% | -$78.7K |
|
29
Procter & Gamble
PG
$368B
| $3.94M | 0.83% |
28,160
-320
| -1% | -$44.7K |
|
30
Salesforce
CRM
$245B
| $3.58M | 0.76% |
13,205
| – | – |
|
31
Aflac
AFL
$57.2B
| $3.44M | 0.73% |
65,981
-194
| -0.3% | -$10.1K |
|
32
Woodward
WWD
$14.8B
| $3.33M | 0.7% |
29,440
| – | – |
|
33
Edwards Lifesciences
EW
$47.8B
| $2.95M | 0.62% |
26,075
| – | – |
|
34
Chevron
CVX
$324B
| $2.64M | 0.56% |
26,047
| – | – |
|
35
Microsoft
MSFT
$3.77T
| $2.41M | 0.51% |
8,553
+60
| +0.7% | +$16.9K |
|
36
JPMorgan Chase
JPM
$829B
| $2.22M | 0.47% |
13,545
| – | – |
|
37
WELLS FARGO 7.5% NON CUMV PERP CONV
WFC.PRL
$4.82B
| $1.74M | 0.37% |
1,175
| – | – |
|
38
AbbVie
ABBV
$372B
| $1.57M | 0.33% |
14,545
| – | – |
|
39
Rithm Capital Corp. 7.125% Series B Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock
RITM.PRB
$284M
| $1.43M | 0.3% |
57,100
| – | – |
|
40
Charles Schwab
SCHW
$174B
| $1.26M | 0.27% |
17,293
| – | – |
|
|
RDS.A
41
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $1.23M | 0.26% |
27,524
| – | – |
|
42
VeriSign
VRSN
$25.5B
| $1.22M | 0.26% |
5,962
| – | – |
|
43
Gilead Sciences
GILD
$140B
| $1.11M | 0.23% |
15,905
-475
| -3% | -$33.2K |
|
44
Verizon
VZ
$186B
| $1.08M | 0.23% |
20,035
| – | – |
|
45
Unum
UNM
$11.9B
| $1.06M | 0.22% |
42,175
+400
| +1% | +$10K |
|
46
Dow Inc
DOW
$17.5B
| $1.04M | 0.22% |
18,105
| – | – |
|
47
Pfizer
PFE
$141B
| $914K | 0.19% |
21,258
| – | – |
|
48
Abbott
ABT
$231B
| $716K | 0.15% |
6,060
| – | – |
|
49
Amgen
AMGN
$155B
| $696K | 0.15% |
3,270
| – | – |
|
50
AT&T
T
$209B
| $649K | 0.14% |
24,042
+81
| +0.3% | +$2.19K |
|